In another active week for the IPO market, eight companies completed offerings, with the largest and most anticipated IPO, Wish (WISH), putting on an underwhelming performance. Surprisingly, this came alongside the best performing IPO of 2020...read more
Virios Therapeutics, a Phase 2 biotech developing novel antiviral therapies for fibromyalgia and other diseases, raised $30 million by offering 3 million shares at $10, within the range of $9 to $11. At pricing, the company commands a market value of $78 million...read more
Virios Therapeutics, a Phase 2 biotech developing novel antiviral therapies for fibromyalgia and other diseases, announced terms for its IPO on Friday.
The Alpharetta, GA-based company plans to raise $30 million by offering 3 million shares at a price range...read more
Two foreign electric vehicle makers and three SPACs went public this past week. A wave of filings brought 27 companies into the IPO pipeline. Xpeng (XPEV), a Chinese electric vehicle maker, upsized and priced above the range to raise $1.5...read more
US IPO Weekly Recap: WISH not granted in week of otherwise stellar returns
In another active week for the IPO market, eight companies completed offerings, with the largest and most anticipated IPO, Wish (WISH), putting on an underwhelming performance. Surprisingly, this came alongside the best performing IPO of 2020...read more
Micro-cap fibromyalgia biotech Virios Therapeutics prices IPO at $10 midpoint
Virios Therapeutics, a Phase 2 biotech developing novel antiviral therapies for fibromyalgia and other diseases, raised $30 million by offering 3 million shares at $10, within the range of $9 to $11. At pricing, the company commands a market value of $78 million...read more
Fibromyalgia biotech Virios Therapeutics sets terms for $30 million IPO
Virios Therapeutics, a Phase 2 biotech developing novel antiviral therapies for fibromyalgia and other diseases, announced terms for its IPO on Friday. The Alpharetta, GA-based company plans to raise $30 million by offering 3 million shares at a price range...read more
US IPO Weekly Recap: The IPO market gears up for fall with wave of filings in a 2 IPO week
Two foreign electric vehicle makers and three SPACs went public this past week. A wave of filings brought 27 companies into the IPO pipeline. Xpeng (XPEV), a Chinese electric vehicle maker, upsized and priced above the range to raise $1.5...read more